Posts by Wavemind
14th International Conference on Structural Biology
The Conference will be held from 24 to 26 September 2018 in Berlin, Germany. Structural Biology 2018 is exclusively designed for Structural Biologists, Bioinformaticians, Biophysicists, Molecular Biologists and others engaged in endeavors related to Structural Biology research and business professionals who are working in this field. This unique opportunity that we extend to our speakers…
Read MoreAddex Pharma – recoit un financement de 1,2 M£
Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as part of the Tools for Human Drug and Brain Research (THuNDR2) Initiative from the Wellcome Trust Collaboration between leading UK neuroscientists, drug development experts and Addex which has been established to study the role of the D1 receptor, the main dopamine…
Read MoreRAPS Switzerland
Chapter Event under the theme “Challenges around the Pediatric Population in Drug Development” RAPS Switzerland Chapter is organizing its first Pharma Educational Event on 20 September 2018 in Bern. Join the event and learn more about PIP, juvenile toxicology, new pediatric regulations, and get your questions answered by an expert panel. More information and registration
Read MoreBerne 14.09.2018 : Conference “Cancer Care 2018 Innovation & Progress in Switzerland”
This Cancer Care 2018 will provide decision makers the latest insights into trends and show opportunities for trans-disciplinary and cross-industry R&D. An ideal meeting point for companies and institutions looking to expand their network and gain visibility within the Cancer Care community. Organizors: INARTIS Network (National Thematic Network (NTN) for Life Sciences) & SAKK (Swiss…
Read MoreLa convergence des technologies: Contributions aux laboratoires du futur
Article BioAlps paru dans le Magazine Chemiextra de septembre 2018, dans le cadre de l’ILMAC Lausanne.
Read MoreAlcon, the eye unit of Novartis will move its headquarters to Geneva after spin-off
On 11 September 2018, Alcon announced that it will move its headquarters to Geneva after spin-off from Novartis. Read full press release
Read MoreLa thérapie génique d’Haya contre les maladies cardiaques
Deux fois par semaine Bilan propose le portrait d’une start-up suisse pour investir issues de sa sélection 2018. Aujourd’hui, Haya Therapeutics et sa thérapie génique contre la fibrose cardiaque. Pour la sixième année consécutive Bilan a dévoilé sa sélection de 50 start-up suisses pour investir ou s’inspirer. Avec 141 start-up présélectionnées par la rédaction de…
Read MoreAIMD Summit
Meet & share with the international Active Implantable Medical Device community on engineering, regulatory and clinical trends. September 12-13th, 2018 – Wyss Center Geneva @ Campus Biotech PRELIMINARY PROGRAMME Technology and Regulatory strategies Update on technological trends MDR reclassification and deadlines Sample sizes for V&V and process validation Embedded software & apps Software classification in…
Read MoreCelgene renforce sa présence à Neuchâtel
Le groupe pharmaceutique américain a inauguré mardi une nouvelle usine à Couvet avec 100 emplois à la clé. Article publié dans le 20 Minutes le 11 septembre 2018 Celgene a inauguré mardi à Couvet (NE) un nouveau site de production devant abriter une centaine d’emplois. L’activité est dédiée aux domaines à haute valeur ajoutée pour la production de…
Read MoreSwiss eHealth Summit 2018
L’événement se déroulera le 11 et 12 septembre 2018 au Stade de Suisse à Berne, sous le thème “Leadership & Digital Transformation”. Cet événement national aura pour objectifs spécifiques les nouveaux défis du passage au numérique lancés aux gestionnaires du milieu hospitalier et des établissements de santé. Informations et Inscriptions
Read More